On CNBC’s “Halftime Report Final Trades,” Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best-performing names in one of the best-performing sectors this year, still having a reasonable valuation of 14 times.
Supporting his view, JP Morgan analyst Chris Schott, on March 27, maintained Gilead Sciences with an Overweight rating and raised the price target from $120 to $130.
Bill Baruch of Blue Line Capital said Amazon.com, Inc. (NASDAQ:AMZN) is ready to rally, with …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades,” Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best-performing names in one of the best-performing sectors this year, still having a reasonable valuation of 14 times.
Supporting his view, JP Morgan analyst Chris Schott, on March 27, maintained Gilead Sciences with an Overweight rating and raised the price target from $120 to $130.
Bill Baruch of Blue Line Capital said Amazon.com, Inc. (NASDAQ:AMZN) is ready to rally, with …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades,” Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best-performing names in one of the best-performing sectors this year, still having a reasonable valuation of 14 times.
Supporting his view, JP Morgan analyst Chris Schott, on March 27, maintained Gilead Sciences with an Overweight rating and raised the price target from $120 to $130.
Bill Baruch of Blue Line Capital said Amazon.com, Inc. (NASDAQ:AMZN) is ready to rally, with …Full story available on Benzinga.com Read MoreAMZN, Bill Baruch, CNBC, GILD, GOOG, GOOGL, Halftime Report Final Trades, Joseph M. Terranova, KLAC, News, Rob Sechan, Stephen Weiss, Markets, Media, Trading Ideas, AMZN, US0231351067, GILD, US3755581036, GOOG, US38259P7069, KLAC, US4824801009, GOOGL, US38259P5089, News, Markets, Media, Trading Ideas, Benzinga Markets
